Properties of Sterol Biosynthesis in Human Leukocytes: Effects of Gemfibrozil
Dr D J Betteridge, Dr M J P Higgins and Dr D J Galton (Lipid Research Laboratory, St Bartholomew's Hospital, London, UK) Errors in metabolic regulation are due to defects in the regulatory properties of enzymes, receptors or carrier proteins (Galton et al. 1975 ). If there is loss of negative feedback inhibition of an enzyme it can give rise to enhanced activity of metabolic pathways and lead to accumulation of terminal metabolites.
Regulatory defects differ from the classical inborn errors of metabolism, where there is a defect in the catalytic activity of enzymes with a consequent accumulation of intermediary metabolites that are not normally found at high concentrations in the body. Therapy directed at catalytic defects is difficult and involves attempts to replace mutant enzymes. However, therapy of regulatory defects of enzymes should, in principle, be simpler, especially when there is loss of negative feedback inhibition ofthe enzyme. In such cases the use of enzyme inhibitors may restore the activity of the unregulated enzyme (and therefore the metabolic pathway) towards normal.
Dr D J Galton
it has recently been demonstrated that familial hypercholesterolmmia is associated with a defect in the regulation of an important ratedetermining enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl coenzyme-A reductase (E.C.I.I.I.34; HMG-CoA reductase). In cultured fibroblasts from patients homozygous for familial hypercholesterolaemia, pre-incubated in lipid-free serum, there is almost complete lack of suppression of HMG-CoA reductase by added low density lipoprotein (Goldstein & Brown 1973) . The failure to suppress HMG-CoA Rudney 1973 ). Enzyme repression possibly involves a nuclear or cytoplasmic aporepressor (Fig 1) for control of transcription of mRNA and results in a decrease in de novo synthesis of HMG-CoA reductase. In familial hypercholesterolEmia it has been variously postulated that there is: (1) A defective cell receptor for combination with LDL (Brown & Goldstein 1974) . (2) A decreased intracellular sterol pool for repression of nuclear transcription (Fogelman et al. 1975 ). This could be due to a greater rate of egress of intracellular cholesterol or a steroid derivative. (3) A defect in LDL which prevents combination with cell receptors (Higgins etal. 1975) .
The observable results of all three cases is that the activity of HMG-CoA reductase is not suppressed in cells incubated with LDL.
Methods
Leukocytes were prepared by mixing blood with two parts by volume of 3% gelatin in isotonic saline containing disodium edetate (2 mmol/l). The mixture was allowed to separate at 37°C for 40 min, after which the supernatant was carefully withdrawn using a siliconized wide-bore pipette. After isolation, the leukocytes were suspended in a tissue culture medium (Minimal Essential Medium, Gibco) and incubated for periods up to 12 h in the presence of lipid-free serum. Transfer of leukocytes to fresh incubation medium containing whole serum was used to study enzyme suppression. Leukocytes prepared in this way actively HMG-CoA reductase was measured at the end of incubation as described by Brown & Goldstein (1974) . Points are means ofduplicate assays in cells heterozygousforfamilial hypercholesterolamia (U-*); and assays in control cells (-0) (Betteridgeetal. 1975 (1975) . HMG-CoA reductase activity was also measured in leukocytes following the methods previously described for fibroblasts (Brown et al. 1973) . The drug was added in 10 ,lI of ethanol to 2 ml of incubation medium. Ethanol was added to control incubations.
Results
The effects of incubating leukocytes for periods up to 12 h in the presence of lipid-free fetal calf serum (20% FCS) is shown in Fig 2. Under these conditions the activity of HMG-CoA reductase is 'derepressed' and isoprenoid biosynthesis is enhanced. Leukocytes from patients heterozygous for familial hypercholesterolhmia show a greater degree of 'depression' than control leukocytes, confirming the results of Fogelman et al. (1975) .
Very little increase in enzyme activity is observed if cells are incubated in untreated 20% fetal calf serum (FCS) . When leukocytes are now transferred to an incubation medium containing LDL (100 ,ug protein/ml) there is marked suppression of enzyme activity over about 8 h (Fig 3) . Patients heterozygous for familial hypercholesterolmmia show incomplete suppression of HMG-CoA reductase when their leukocytes are incubated with LDL (Fig 3) . The effects of gemfibrozil on the derepression phase of the enzyme in leukocytes is shown in Fig 4. The ethanol blank produces slight inhibition of acetate incorporation into isoprenoids, and this inhibition is more marked in the presence of gemfibrozil at 2 and 3 mM. However at high concentrations of the drug, aggregation of leukocytes occurs, and this may be partly responsible for the reduced incorporation of acetate into isoprenoids.
Conclusions
Isoprenoid biosynthesis in human leukocytes is regulated by lipoproteins, and this is probably mediated by changes in the activity of a ratedetermining enzyme HMG-CoA reductase. Defects in the regulation of this enzyme can be observed in leukocytes from patients with familial hypercholesterolkmia. One defect is enhanced activity of the enzyme when leukocytes are incubated in a lipid-free medium; another is a failure of suppression of HMG-CoA reductase when leukocytes are incubated in a lipoproteinrich medium. Agents which can prevent 'derepression' of the enzyme, or alternatively, agents which can enhance suppression of the enzyme, may be of use in the treatment of familial hypercholesterolhmia. Use of gemfibrozil has been studied, and at concentrations of 2 to 3 mM it reduces 14C-acetate incorporation into isoprenoids as well as producing leukocyte aggregation.
